France· FR:63152345
ABACAVIR/LAMIVUDINE/ZIDOVUDINE VIATRIS 300 mg/150 mg/300 mg, comprimé pelliculé
A medicinal product, registered in France by VIATRIS SANTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093012310260 plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 1 comprimé(s)EUR 235.14
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ABACAVIR/LAMIVUDINE/ZIDOVUDINE in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRIZIVIRViiV Healthcare BV, Amersfoort
- SpainTRIZIVIR 300 MG/150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- IrelandTrizivir 300 mg/150 mg/300 mg film-coated tabletsViiV Healthcare BV
- NetherlandsAbacavir/Lamivudine/Zidovudine Mylan 300 mg/150 mg/300 mg filmomhulde tablettenMylan Pharmaceuticals Limited
- United KingdomTrizivir 300mg/150mg/300mg tabletsViiV Healthcare UK Ltd
- FinlandTRIZIVIRViiV Healthcare BV
- IcelandTrizivirViiV Healthcare BV
- United StatesABACAVIR, LAMIVUDINE AND ZIDOVUDINELupin Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Iceland · Trizivir
- Italy · Abacavir/Lamivudina/Zidovudina Mylan
- Liechtenstein · Trizivir
- Netherlands · Abacavir/Lamivudine/Zidovudine Mylan
- Norway · Trizivir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/07b33360-f153-4b85-bd10-87e24a6ac543 GET /v1/drugs/07b33360-f153-4b85-bd10-87e24a6ac543?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63152345",
"date_amm": "2017-12-21",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ABACAVIR/LAMIVUDINE/ZIDOVUDINE.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.